Primary Tumor Volume is an Independent Predictor of Outcome Within PT4a-staged Tongue Carcinoma
Overview
Affiliations
Background: We evaluated the heterogeneity of primary tumor volume (PTV) within tumors of the same pT4a-staged tongue carcinoma and to elucidate the effects of PTV on treatment outcomes in patients with pT4a-staged tongue carcinoma.
Methods: Fifty-eight patients with newly diagnosed pT4a-staged tongue carcinoma who received surgery were enrolled onto this study. Magnetic resonance imaging-derived PTV was measured by the summation-of-area technique.
Results: The mean PTV was 24.55 ml, with a range of 5.32 to 119.64 ml. The receiver operating characteristic curve was applied, and the optimal cutoff volume was 23 ml. Large PTV was associated with a significantly poor disease-specific survival (P = 0.010) by the log rank test. The Cox regression model also revealed that large PTV (P = 0.026) and positive lymphatic node metastasis (P = 0.004) were statistically significant in the prognosis of T4a-staged tongue carcinoma.
Conclusions: A substantial variation of PTV was present within the same pT4a-staged tongue carcinoma, and PTV represented an important prognostic factor. In the light of these findings, we suggest that taking the PTV into account in pT4a-staged tongue carcinoma would better refine the newest revised T classification, and the treatment strategies may be different.
Mijatov I, Kiralj A, Ilic M, Vuckovic N, Spasic A, Nikolic J Oncol Lett. 2023; 25(3):94.
PMID: 36817058 PMC: 9932573. DOI: 10.3892/ol.2023.13679.
The evolution of nasopharyngeal carcinoma staging.
Guo R, Mao Y, Tang L, Chen L, Sun Y, Ma J Br J Radiol. 2019; 92(1102):20190244.
PMID: 31298937 PMC: 6774596. DOI: 10.1259/bjr.20190244.
Kwon M, Moon H, Nam S, Lee J, Kim J, Lee Y Eur Radiol. 2015; 26(3):858-65.
PMID: 26108641 DOI: 10.1007/s00330-015-3884-z.
Hu H, Cheng K, Xu X, Wu F, Tyan Y, Tsai C AJNR Am J Neuroradiol. 2015; 36(7):1338-42.
PMID: 25836729 PMC: 7965280. DOI: 10.3174/ajnr.A4278.
Influence of tumor volume on survival in patients with oral squamous cell carcinoma.
Mucke T, Mitchell D, Ritschl L, Tannapfel A, Wolff K, Kesting M J Cancer Res Clin Oncol. 2014; 141(6):1007-11.
PMID: 25423880 DOI: 10.1007/s00432-014-1881-2.